CONTRACT REDLINE & NEGOTIATION
Finalizing the clinical trial agreement is one of the most consistent bottlenecks in study start-up. And when contracts do get signed without a thorough review, which happens more often than it should, sites pay for it twice: once in time, and once in exposure to risk they did not intend to carry.
Sponsors and CROs draft agreements that protect their interests. Without skilled, specific review on your side, terms that place unnecessary liability on your site make it through to execution.
Contracts protect sponsors by default. We make sure they protect your site too.
THE PROBLEM
Generic review misses what matters in a Clinical trial analysis
At smaller sites, contract review often falls to someone without CTA-specific training. At larger institutions, it typically lands with a legal or contracts team that handles every agreement the organization touches, not just clinical trial agreements.
CTA language is specialized. The nuances matter. A provision that looks standard in a general commercial agreement can carry very different implications in the context of a clinical trial. Generic review misses those distinctions. CTA-specific expertise catches them.
Reduced legal exposure
Every agreement is reviewed with CTA-specific expertise. Terms that place unnecessary risk on your site are identified and negotiated before you sign, not discovered afterward.
Clarity on responsibilities before issues arise
Ambiguous contract language sets up disputes. We make sure both parties have a clear, mutual understanding of what they are agreeing to so there are no surprises during execution.
Faster start-up timelines, across every study
With a solid playbook in place and experienced negotiators handling the back-and-forth, contract cycles get shorter. That time savings compounds across every study your site runs
WHAT WE DO
What changes when Elevate handles your budget
Expert review, faster cycles, less exposure
We review, redline, and negotiate clinical trial agreements on behalf of your site. We know the language, we know what sponsors will move on, and we know how to get to a final agreement efficiently, without unnecessary back-and-forth or prolonged cycles that delay activation.
We also build and maintain contract playbooks which are site-specific documents that define your must-haves, your preferred positions, and your acceptable terms across different trial types. A well-built playbook compresses negotiation time on every study that follows.
WHAT YOU GET
Hidden costs identified and recovered before the study starts.
A clear picture of financial feasibility before you commit.
Faster start-up timelines, across every study
FAQ
-
A playbook is a site-specific reference document that defines your must-haves, preferred positions, and acceptable terms across different trial types. You don't need one to start working with us, but building one significantly shortens negotiation cycles on every study that follows, so we recommend it for any site negotiating agreements regularly.
-
It varies by sponsor and trial complexity, but sites working with us generally see shorter cycles than negotiating without CTA-specific expertise, particularly once a playbook is in place to guide initial positions.
-
We negotiate directly on your behalf. How much visibility or involvement your team wants in that process is customized to your institution's preferences.
Protect Your Site Before You Sign
Connect with our team and see what CTA-specific review catches.